Nikitin E A, Malakho S G, Biderman B V, Baranova A V, Lorie Y Y, Shevelev A Y, Peklo M M, Vlasik T N, Moskalev E A, Zingerman B V, Vorob'ev I A, Poltaraus A B, Sudarikov A B, Vorobjev A I
Hematology Research Center of Russia, Moscow, Russia.
Leuk Lymphoma. 2007 May;48(5):912-22. doi: 10.1080/10428190701245112.
Mutational status of immunoglobulin variable region genes (VH-genes) is known as the strongest predictor of long term prognosis in B-CLL. However, applications in the routine clinical practice are time consuming, and therefore some other predictions are required. In this study, we have compared prognostic values of real time PCR quantification of the expression levels of four genes previously shown to be differentially expressed in V(H)-unmutated and mutated B-CLL subtypes: ZAP-70, ZBTB20, DMD and LPL. The study included 134 B-CLL patients. Expression levels of LPL and DMD genes were significantly correlated to mutational status, while expression levels of of ZAP-70 gene correlated only in CD19+ selected cases (N = 40). No correlation was observed for ZBTB20 gene. Expression levels of LPL and DMD predicted overall survival in the entire cohort of patients. Prognostic values of LPL gene expression levels were significant even for CLL patients with stage A. Quantitative RT-PCR assays for measuring LPL gene expression are robust enough to be introduced into routine clinical practice.
免疫球蛋白可变区基因(VH基因)的突变状态是B细胞慢性淋巴细胞白血病(B-CLL)长期预后的最强预测指标。然而,在常规临床实践中的应用耗时,因此需要其他一些预测方法。在本研究中,我们比较了实时PCR定量检测先前显示在V(H)未突变和突变的B-CLL亚型中差异表达的四个基因(ZAP-70、ZBTB20、DMD和LPL)表达水平的预后价值。该研究纳入了134例B-CLL患者。LPL和DMD基因的表达水平与突变状态显著相关,而ZAP-70基因的表达水平仅在CD19+选择的病例(N = 40)中相关。未观察到ZBTB20基因的相关性。LPL和DMD的表达水平预测了整个患者队列的总生存期。即使对于A期的CLL患者,LPL基因表达水平的预后价值也很显著。用于测量LPL基因表达的定量RT-PCR检测方法足够可靠,可引入常规临床实践。